Branded medicines statutory scheme consultation concluded
The Department of Health and Social Care (DHSC) has published the results of the consultation changes to the Statutory Scheme … read more »
EMA statement clarifies Brexit situation
The European Medicines Agency (EMA) has released a statement to mark the start of the transition period between the UK … read more »
NIHR and Novartis agree large scale clinical trial cardiovascular disease drug
A new deal will see the NHS involved in supporting a large scale trial of the drug, which it is … read more »
Restoration of power sharing in Northern Ireland brings news for health sector
The deal to resume power sharing in Northern Ireland has been accepted by the major political parties of the country, … read more »
NICE Chief Executive Sir Andrew Dillon to stand down
The Chief Executive of NICE, Sir Andrew Dillon, is stepping down at the end of March 2020 after completing over … read more »
NICE 20th Anniversary: Parliamentary Reception and Awards
In celebration of its 20th Anniversary, NICE hosted a parliamentary reception and award celebration. Sir David Haslam, chair of the … read more »
BIA chief executive reasserts harm to UK life sciences of no-deal Brexit
Steve Bates, chief executive of BIA, told the Exiting the EU Committee there are short- and long-term negative impacts of … read more »
APRHAI 9th annual report
The Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI) has published its 9th annual report. The report … read more »
England’s Chief Medical Officer calls for industry to conduct trials into medicinal cannabis
England’s Chief Medical Officer, Professor Dame Sally Davies, has called on industry to play a leading role in conducting clinical … read more »
US Trade Plan could harm NHS, claim People’s Vote Campaign
The People’s Vote Campaign claim that the recently-published US Objectives for negotiating a UK trade deal portent the erosion of … read more »
